Preliminary results of the INSPIRE trial with the novel MGuard™ stent system containing a protection net to prevent distal embolization

Abstract

In this preliminary evaluation, the MGuard device demonstrated excellent performance in a highly complex lesion subset, including absence of angiographic/procedural complications, and no adverse events up to 30-day FU.